Nab-Paclitaxel or Docetaxel as Alternatives to Solvent-Based Paclitaxel in Metastatic Breast Cancer (Mbc)- A Cost Utility Analysis from a Chinese Health Care Perspective
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.2320
https://www.valueinhealthjournal.com/article/S1098-3015(14)04250-8/fulltext
Title :
Nab-Paclitaxel or Docetaxel as Alternatives to Solvent-Based Paclitaxel in Metastatic Breast Cancer (Mbc)- A Cost Utility Analysis from a Chinese Health Care Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04250-8&doi=10.1016/j.jval.2014.08.2320
First page :
A642
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1775